China SXT Pharmaceuticals, Inc. SEC filings SXTC
China SXT Pharmaceuticals, Inc. has 169 filings in SEC EDGAR's recent list, going back to Dec 4, 2017. Its latest annual report, Form 20-F, was filed on Jul 1, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Oct 21, 2026. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 21, 2026 | Oct 21, 2026 |
| 6-K | Current report (foreign issuer) | Oct 9, 2026 | Oct 9, 2026 |
| 6-K | Current report (foreign issuer) | Oct 8, 2026 | Oct 8, 2026 |
| 6-K | Current report (foreign issuer) | Oct 8, 2026 | Oct 8, 2026 |
| 6-K | Current report (foreign issuer) | Aug 28, 2026 | Aug 28, 2026 |
| 6-K | Current report (foreign issuer) | Jul 24, 2026 | Jul 24, 2026 |
| 6-K | Current report (foreign issuer) | Jul 6, 2026 | Jul 6, 2026 |
| 6-K | Current report (foreign issuer) | Jun 1, 2026 | Jun 1, 2026 |
| 6-K | Current report (foreign issuer) | May 4, 2026 | May 4, 2026 |
| 6-K | Current report (foreign issuer) | Apr 9, 2026 | Apr 9, 2026 |
| 6-K | Current report (foreign issuer) | Jan 13, 2026 | Jan 13, 2026 |
| 6-K | Current report (foreign issuer) | Dec 31, 2025 | Sep 30, 2025 |
| 6-K | Current report (foreign issuer) | Jul 29, 2025 | Jul 29, 2025 |
| 6-K | Current report (foreign issuer) | Jul 15, 2025 | Jul 15, 2025 |
| 6-K | Current report (foreign issuer) | Jun 16, 2025 | Jun 16, 2025 |
| 6-K | Current report (foreign issuer) | May 13, 2025 | May 13, 2025 |
| 6-K | Current report (foreign issuer) | Mar 28, 2025 | Sep 30, 2024 |
| 6-K | Current report (foreign issuer) | Mar 19, 2025 | Mar 19, 2025 |
| 6-K | Current report (foreign issuer) | Jan 27, 2025 | Jan 27, 2025 |
| 6-K | Current report (foreign issuer) | Jan 23, 2025 | Jan 23, 2025 |
| 6-K | Current report (foreign issuer) | Oct 15, 2024 | Oct 15, 2024 |
| 6-K | Current report (foreign issuer) | May 14, 2024 | May 14, 2024 |
| 6-K | Current report (foreign issuer) | Apr 5, 2024 | Sep 30, 2023 |
| 6-K | Current report (foreign issuer) | Mar 23, 2023 | Mar 23, 2023 |
| 6-K | Current report (foreign issuer) | Feb 28, 2023 | Feb 28, 2023 |
| 6-K | Current report (foreign issuer) | Feb 24, 2023 | Sep 30, 2022 |
| 6-K | Current report (foreign issuer) | Dec 23, 2022 | Dec 22, 2022 |
| 6-K | Current report (foreign issuer) | Oct 12, 2022 | Oct 12, 2022 |
| 6-K | Current report (foreign issuer) | Sep 27, 2022 | Sep 27, 2022 |
| 6-K | Current report (foreign issuer) | May 13, 2022 | May 13, 2022 |
| 6-K | Current report (foreign issuer) | May 11, 2022 | May 11, 2022 |
| 6-K | Current report (foreign issuer) | Mar 24, 2022 | Mar 24, 2022 |
| 6-K | Current report (foreign issuer) | Mar 16, 2022 | Mar 16, 2022 |
| 6-K | Current report (foreign issuer) | Feb 9, 2022 | Feb 8, 2022 |
| 6-K | Current report (foreign issuer) | Jan 31, 2022 | Jan 31, 2022 |
| 6-K | Current report (foreign issuer) | Jan 21, 2022 | Jan 20, 2022 |
| 6-K | Current report (foreign issuer) | Jan 14, 2022 | Sep 30, 2021 |
| 6-K | Current report (foreign issuer) | May 26, 2021 | May 26, 2021 |
| 6-K | Current report (foreign issuer) | May 17, 2021 | May 17, 2021 |
| 6-K | Current report (foreign issuer) | Apr 8, 2021 | Apr 8, 2020 |
| 6-K | Current report (foreign issuer) | Mar 3, 2021 | Mar 2, 2021 |
| 6-K | Current report (foreign issuer) | Feb 16, 2021 | Feb 16, 2021 |
| 6-K | Current report (foreign issuer) | Feb 3, 2021 | Feb 3, 2021 |
| 6-K | Current report (foreign issuer) | Jan 28, 2021 | Sep 30, 2020 |
| 6-K | Current report (foreign issuer) | Dec 3, 2020 | Dec 1, 2020 |
| 6-K | Current report (foreign issuer) | Jul 10, 2020 | Jul 10, 2020 |
| 6-K/A | Amendment to report of foreign private issuer | May 22, 2020 | Sep 30, 2019 |
| 6-K | Current report (foreign issuer) | Apr 22, 2020 | Sep 30, 2019 |
| 6-K | Current report (foreign issuer) | Mar 31, 2020 | Mar 31, 2020 |
| 6-K | Current report (foreign issuer) | Mar 10, 2020 | Mar 10, 2020 |
| 6-K | Current report (foreign issuer) | Mar 4, 2020 | Mar 3, 2020 |
| 6-K | Current report (foreign issuer) | Jan 31, 2020 | Jan 31, 2020 |
| 6-K | Current report (foreign issuer) | Dec 16, 2019 | Dec 16, 2019 |
| 6-K | Current report (foreign issuer) | Jul 31, 2019 | Jul 31, 2019 |
| 6-K | Current report (foreign issuer) | May 3, 2019 | May 3, 2019 |
| 6-K | Current report (foreign issuer) | Apr 17, 2019 | Apr 17, 2019 |
| 6-K | Current report (foreign issuer) | Mar 28, 2019 | Mar 27, 2019 |
Showing 57 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SXTC (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Virgin Islands, British
- Headquarters
- Taizhou
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1723980
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.